Articles published by Merck & Co., Inc.![]() ![]() ![]() ![]() ![]() ![]()
Merck Announces Third-Quarter 2023 Dividend
May 23, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]() ![]() ![]() ![]()
Merck Announces First-Quarter 2023 Financial Results
April 27, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Merck Provides Update on Phase 3 Trials KEYNOTE-641 and KEYNOTE-789
February 28, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]()
Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO™ (Molnupiravir)
February 24, 2023
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|